Bellicum Pharmaceuticals Appoints Dr. William Grossman as Chief Medical Officer Read more about Bellicum Pharmaceuticals Appoints Dr. William Grossman as Chief Medical Officer
Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States Read more about Bellicum Pharmaceuticals Announces Clinical Hold on BPX-501 Clinical Trials in the United States
Bellicum Pharmaceuticals Announces Presentations of its Controllable Switch Technology Platform at the American Society of Hematology 2017 Annual Meeting Read more about Bellicum Pharmaceuticals Announces Presentations of its Controllable Switch Technology Platform at the American Society of Hematology 2017 Annual Meeting
Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem Cell Transplant with BPX-501 in Children with Blood Cancers and Nonmalignant Diseases Read more about Bellicum Announces Data Presentation Demonstrating Improved Immune Recovery Following Haploidentical Stem Cell Transplant with BPX-501 in Children with Blood Cancers and Nonmalignant Diseases
Bellicum Pharmaceuticals to Present at the Jefferies 2017 London Healthcare Conference Read more about Bellicum Pharmaceuticals to Present at the Jefferies 2017 London Healthcare Conference
Bellicum Reports Third Quarter 2017 Financial Results Read more about Bellicum Reports Third Quarter 2017 Financial Results
Bellicum Announces Data Presentations on Lead Product Candidate BPX-501 and CAR-T Program at the 59th American Society of Hematology Annual Meeting Read more about Bellicum Announces Data Presentations on Lead Product Candidate BPX-501 and CAR-T Program at the 59th American Society of Hematology Annual Meeting
Bellicum Pharmaceuticals to Present at Three Healthcare Investor Conferences in September Read more about Bellicum Pharmaceuticals to Present at Three Healthcare Investor Conferences in September
Bellicum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update Read more about Bellicum Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Bellicum Pharmaceuticals Appoints Gregory Naeve as Chief Business Officer Read more about Bellicum Pharmaceuticals Appoints Gregory Naeve as Chief Business Officer